Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

A woman's hair turned white after taking a cancer drug called dasatinib.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Butin is effective in treating vitiligo in mice.

Compound 4 is a promising treatment for hair loss with low toxicity.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Cepharanthine shows promise as a natural anticancer treatment.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.